MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

503937

Report Date :

13.04.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

USV PRIVATE LIMITED (w.e.f. 02.11.2015)

 

 

Formerly Known As :

USV LIMITED (w.e.f. 13.05.1993)

 

U. S. VITAMIN AND PHARMACEUTICAL CORPORATION (INDIA) PRIVATE LIMITED

 

 

Registered Office :

Arvind Vithal Gandhi Chowk, B S D Marg, Govandi, Mumbai – 400088, Maharashtra

Tel. No.:

91-22-25564048 / 67861111

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

25.08.1961

 

 

Com. Reg. No.:

11-012098

 

 

Capital Investment / Paid-up Capital :

INR 978.910 Million 

 

 

CIN No.:

[Company Identification No.]

U24239MH1961PTC012098

 

 

IEC No.:

[Import-Export Code No.]

0388147407

 

 

GSTN :

[Goods & Service Tax Registration No.]

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACU1366N 

 

 

Legal Form :

Private Limited Liability Company.

 

 

Line of Business :

Subject is engaged in the manufacturing and sale of Active Pharmaceutical Ingredients (API), finished dosages both branded and generics. [Registered Activity]

 

 

No. of Employees :

Information denied by the management

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A++

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

 

Maximum Credit Limit :

USD 58000000

 

 

Status :

Excellent

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Exist

 

 

Comments :

Subject was incorporated in the year 1961. It is engaged in manufacturing and selling of Active Pharmaceutical Ingredients (API), finished dosages both branded and generics.

 

For the financial year 2017, the company has achieved revenue growth of 11.45% as compared to the previous year along with a decent profit margin of 22.78%.

 

The sound financial risk profile of the company is marked by adequate networth base along with strong debt coverage indicators due to debt free balance sheet profile.

 

Rating takes into consideration the subject’s healthy Earnings Per Share of INR 60.81 against the Face Value of INR 10.

 

Rating takes into account the subject’s long established track record of business operations along with extensive experience of its promoters.

 

Payments seems to be regular.

 

In view of aforesaid, the company can be considered good for business dealings at usual trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long Term Bank Facilities= AA+

Rating Explanation

High degree of safety and very low credit risk.

Date

31.03.2017

 

 

Rating Agency Name

CRISIL

Rating

Short Term Bank Facilities= A1+

Rating Explanation

Very strong degree of safety and carry lowest credit risk.

Date

31.03.2017

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 13.04.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION DENIED

 

Management Non-Cooperative (91-22-25564048)

 

LOCATIONS

 

Registered Office :

Arvind Vithal Gandhi Chowk, B S D Marg, Govandi, Mumbai – 400088, Maharashtra, India

Tel. No.:

91-22-25564048 / 67861111

Fax No.:

91-22-25584025

E-Mail :

sudhir.thatte@usv.in

rajesh.padwal@usv.in

info@usv.in

Website :

http://www.usvindia.com

Location :

Owned

Locality :

Commercial

 

 

Factory :

B-1/8, B-8, B-9, B-10, MIDC, Lote Parashuram, Ratnagiri – 415722, Maharashtra, India

 

 

Factories :

Located at :

 

·         M.I.D.C. Lote Industrial Area, Khed, Ratnagiri, Maharashtra, India

·         Chiplun, Maharashtra, India

·         Nerul, New Mumbai, Maharashtra, India

·         OIDC, Dabhel, Daman, Daman and Diu, India

·         HPSIDC, Baddi, Himachal Pradesh, India

·         Hilltop Industrial Area, Jharmajri, Baddi, Himachal Pradesh, India

 

DIRECTORS

 

AS ON 31.03.2018

 

Name :

Mr. Prashant Kumar Tewari

Designation :

Managing Director

Address :

41, Ritu Apartments, 208, B.J. Road, Bandra (West), Mumbai – 400050, Maharashtra, India

Date of Birth/Age :

09.04.1958

Qualification :

MS, B. Tech, IIT Kanpur

Date of Appointment :

01.05.2008

PAN No.:

AAAPT6427C

DIN No.:

00001745

 

 

Name :

Mrs. Leena Gandhi Tewari

Designation :

Director

Address :

41, Ritu Apartments, 208, B.J. Road, Bandra (West), Mumbai – 400050, Maharashtra, India

Date of Birth/Age :

09.03.1957

Qualification :

MBA, Boston University, USA, B. Com.

Date of Appointment :

20.01.1986

PAN No.:

AAFPG5709D

DIN No.:

00001748

 

 

Name :

Debabrata Bhadury

Designation :

Director

Address :

9A, Belvedere Court, Sane Guruji Marg, Mahalaxmi, Mumbai – 400011, Maharashtra, India

Date of Birth/Age :

20.11.1941

Qualification :

MA (Economics)

Date of Appointment :

01.05.2001

DIN No.:

00001754

 

 

Name :

Mr. Deepak Keshav Ghaisas

Designation :

Director

Address :

B/61-62, Swapnashilp, Mahant Road, Vile Parle (East), Mumbai – 400057, Maharashtra, India

Date of Birth/Age :

19.11.1957

Qualification :

CA, CS and ICWA

Date of Appointment :

23.08.2003

DIN No.:

00001811

 

 

Name :

Murugappan Muthiah Venkatachalam

Designation :

Director

Address :

20/1, Valliammai Achi Road, Kotturpuram, Chennai – 600085, Tamilnadu, India

Date of Birth/Age :

24.11.1958

Qualification :

MBA, Washington University, United States of America

Date of Appointment :

31.07.2007

DIN No.:

00152619

 

 

Name :

Vilas Gandhi Tewari

Designation :

Director

Address :

5416, Fair Ave Apt 1321 N Hollywood CA 91601 USA

Date of Appointment :

27.09.2012

DIN No.:

05354249

 

 

KEY EXECUTIVES

 

Name :

Mr. Akhilesh Jain

Designation :

Company Secretary

Address :

Flat No.A-404, Plot No.23 A, Sector-6 Vihang Residency, Nerul (West), Navi Mumbai – 400706, Maharashtra, India

Date of Appointment :

23.09.2017

PAN No.:

AFXPJ9171R

 

 

Name :

Mr. Prakash Chandrasekharan Menon

Designation :

Chief Financial Officer

Date of Appointment :

18.06.2014

PAN No.:

AACPM8929L

 

 

Name :

Mr. Halde

Designation :

Purchase Department

 

 

Name :

Mr. Vijay

Designation :

Accounts Department

 

 

MAJOR SHAREHOLDERS

 

AS ON 31.03.2017

 

Names of Shareholders

 

No. of Shares

Leena Gandhi Tewari

 

94715652

Prashant Kumar Tewari

 

3175622

Vilas Gandhi Tewari

 

6

Vilas Family Trust

 

100

Aneesha Gandhi Tewari

 

6

Aneesha Family Trust

 

100

 

 

 

Total

 

97891486

 

Equity Share Break up (Percentage of Total Equity)

 

AS ON 11.07.2017

 

Category

Percentage

Promoters [Individual/Hindu Undivided Family (Indian)]

99.99978343

Promoters [Individual/Hindu Undivided Family (Foreign national {other than NRI})]

0.00001226

Promoters [Others (Two Family Trusts)]

0.00020431

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in the manufacturing and sale of Active Pharmaceutical Ingredients (API), finished dosages both branded and generics. [Registered Activity]

 

 

Products / Services :

Name and Description of main products / services

ITC Code

Formulations

30049099

Bulk Drugs

29252990

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged 

 

 

Imports :

Not Divulged 

 

 

Terms :

Not Divulged 

 

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged 

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark :

--

 

 

Customers :

 

Reference :

Not Divulged 

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark :

--

 

 

No. of Employees :

Information denied by the management

 

 

Bankers :

Banker Name :

State Bank of India

Branch :

Mid Corporate Loan Adm. Unit, Shree Hari Building, RTO Lane, Four Bunglows, Andheri (West), Mumbai – 400053, Maharashtra, India

Person Name (With Designation) :

--

Contact Number :

--

Name of Account Holder :

--

Account Number :

--

Account Since (Date/Year of Account Opening) :

--

Average Balance Maintained :

--

Credit Facilities Enjoyed (CC/OD/Term Loan) :

--

Account Operation :

--

Remark :

--

 

Auditors :

 

Name :

B S R and Company LLP

Chartered Accountants

Address :

301 C Wing, New Sarvottam CHS, L S V Road, Near Irla Bridge, Andheri (West), Mumbai – 400058, Maharashtra, India

PAN No.:

AAAFB9852F

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Subsidiary companies :

·         Indicus Pharma LLC, United States

·         USV Europe Limited, United Kingdom

·         Bharavi Laboratories Private Limited, India

·         USV North America, Inc., United States

·         Aviat Health Care Private Limited, India

·         USV Labs Private Limited

 

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives :

·         V. B. Gandhi and Company, India

·         Treva Health Care Private Limited, India

·         Vipal Health Care Private Limited, India

·         USV Reliable Homes Private Limited, India

·         Neo Pharma Industries Private Limited, India

·         V-Kidd Computer Graphics Private Limited

·         Tender Management Consultants LLP

 

 

CAPITAL STRUCTURE

 

AS ON 11.07.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

125000000

Equity Shares

INR 10/- each

INR 1250.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

97891486

Equity Shares

INR 10/- each

INR 978.915 Million

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET (STANDALONE)

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

978.910

999.670

999.670

(b) Reserves and Surplus

19425.670

17000.270

14890.970

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

20404.580

17999.940

15890.640

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

150.210

(c) Other long-term liabilities

717.910

829.670

0.000

(d) long-term provisions

486.070

443.210

57.230

Total Non-current Liabilities (3)

1203.980

1272.880

207.440

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

0.000

0.000

0.000

(b) Trade payables

2429.050

2236.340

1949.060

(c) Other current liabilities

965.790

971.200

561.160

(d) Short-term provisions

625.870

513.560

3586.630

Total Current Liabilities (4)

4020.710

3721.100

6096.850

 

 

 

 

TOTAL

25629.270

22993.920

22194.930

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

3429.270

3208.740

3404.840

(ii) Intangible Assets

418.900

488.890

77.840

(iii) Tangible assets capital work-in-progress

1529.020

1412.610

423.330

(iv) Intangible assets under development

241.480

0.000

0.000

(b) Non-current Investments

1718.480

2010.420

1407.050

(c) Deferred tax assets (net)

1637.520

1732.210

0.000

(d) Long-term loans and advances

146.980

97.830

1921.890

(e) Other Non-current assets

313.140

412.800

1.660

Total Non-Current Assets

9434.790

9363.500

7236.610

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

9506.450

7617.130

9791.290

(b) Inventories

2710.980

2280.380

1945.840

(c) Trade receivables

2051.150

2144.680

1883.710

(d) Cash and bank balances

823.950

835.720

666.790

(e) Short-term loans and advances

201.780

111.190

663.610

(f) Other current assets

900.170

641.320

7.080

Total Current Assets

16194.480

13630.420

14958.320

 

 

 

 

TOTAL

25629.270

22993.920

22194.930

 

 

PROFIT & LOSS ACCOUNT (STANDALONE)

 

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Total Revenue from operations

26552.700

23825.180

20758.950

 

Other Income

1195.830

1549.790

973.320

 

TOTAL

27748.530

25374.970

21732.270

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

3441.290

3450.670

3591.270

 

Purchases of Stock-in-Trade

5084.010

4572.590

3708.170

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(361.780)

(395.250)

(70.640)

 

Employee benefit expense

2881.190

2479.070

2079.545

 

CSR expenditure

81.940

34.810

45.200

 

Other expenses

8082.810

7052.540

5737.845

 

TOTAL

19209.460

17194.430

15091.390

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

8539.070

8180.540

6640.880

 

 

 

 

 

Less

FINANCIAL EXPENSES

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

8539.070

8180.540

6640.880

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION

803.590

827.280

987.610

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

7735.480

7353.260

5653.270

 

 

 

 

 

Less

TAX

1686.060

1440.220

1218.990

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

6049.420

5913.040

4434.280

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

NA

4433.000

3947.840

 

TOTAL EARNINGS

NA

4433.000

3947.840

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

NA

1065.130

1008.410

 

Components and spare parts

NA

195.590

105.840

 

Capital Goods

NA

552.620

164.920

 

TOTAL IMPORTS

NA

1813.340

1279.170

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

60.81

59.15

44.36

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

0.000

1.140

3.950

Cash generated from operations

NA

NA

NA

Net cash flows from (used in) operations

7306.050

6645.330

5772.940

Net cash flows from (used in) operating activities

5684.350

5043.150

4534.160

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

28.20

32.86

33.12

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

12.95

11.11

11.02

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

104.00

101.74

97.46

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

3.15

3.59

3.41

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

1.52

1.60

1.70

 

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.16

0.16

0.27

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.00

0.00

0.00

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.20

0.21

0.38

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.28

0.28

0.25

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

0.00

0.00

0.00

 

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

PAT to Sales

((PAT / Sales) * 100)

%

22.78

24.82

21.36

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

23.60

25.72

19.98

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

29.65

32.85

27.90

 

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

4.03

3.66

2.45

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

3.35

3.05

2.13

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.80

0.78

0.72

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

0.00

0.00

0.00

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

4.03

3.66

2.45

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Share Capital

999.670

999.670

978.910

Reserves & Surplus

14890.970

17000.270

19425.670

Net worth

15890.640

17999.940

20404.580

 

 

 

 

Long-term borrowings

0.000

0.000

0.000

Short term borrowings

0.000

0.000

0.000

Current maturities of long-term debts

3.950

1.140

0.000

Total borrowings

3.950

1.140

0.000

Debt/Equity ratio

0.000

0.000

0.000

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

20758.950

23825.180

26552.700

 

 

14.771

11.448

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

20758.950

23825.180

26552.700

Profit/ (Loss)

4434.280

5913.040

6049.420

 

21.36 %

24.82 %

22.78 %

 

 

 

ABRIDGED BALANCE SHEET (CONSOLIDATED)

 

SOURCES OF FUNDS

 

 

31.03.2017

31.03.2016

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

978.910

999.670

(b) Reserves and Surplus

 

19257.720

16622.610

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

10.520

11.460

Total Shareholders’ Funds (1) + (2)

 

20247.150

17633.740

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

0.000

0.000

(b) Deferred tax liabilities (Net)

 

0.000

0.000

(c) Other long-term liabilities

 

410.440

499.990

(d) long-term provisions

 

486.670

443.940

Total Non-current Liabilities (3)

 

897.110

943.930

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

 

0.000

0.000

(b) Trade payables

 

2422.820

2234.990

(c) Other current liabilities

 

1663.010

1516.900

(d) Short-term provisions

 

626.170

513.590

Total Current Liabilities (4)

 

4712.000

4265.480

 

 

 

 

TOTAL

 

25856.260

22843.150

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

3450.510

3236.600

(ii) Intangible Assets

 

425.400

495.390

(iii) Tangible assets capital work-in-progress

 

1529.020

1412.610

(iv) Intangible assets under development

 

241.480

0.000

(b) Non-current Investments

 

1671.550

1997.360

(c) Deferred tax assets (net)

 

1221.070

1254.500

(d) Long-term loans and advances

 

148.790

99.620

(e) Other Non-current assets

 

454.080

426.330

Total Non-Current Assets

 

9141.900

8922.410

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

9506.450

7617.130

(b) Inventories

 

2716.650

2285.910

(c) Trade receivables

 

2132.290

2212.110

(d) Cash and bank balances

 

1473.210

1114.800

(e) Short-term loans and advances

 

126.610

48.900

(f) Other current assets

 

759.150

641.890

Total Current Assets

 

16714.360

13920.740

 

 

 

 

TOTAL

 

25856.260

22843.150

 

 

PROFIT & LOSS ACCOUNT (CONSOLIDATED)

 

 

PARTICULARS

 

 

31.03.2017

31.03.2016

 

SALES

 

 

 

 

Total Revenue from operations

 

27113.980

24241.510

 

Other Income

 

1190.650

1187.020

 

TOTAL

 

28304.630

25428.530

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

 

3441.830

3453.240

 

Purchases of Stock-in-Trade

 

5084.010

4572.590

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

(362.070)

(395.350)

 

Employee benefit expense

 

3007.720

2550.460

 

CSR expenditure

 

81.940

34.810

 

Other expenses

 

8173.900

7098.550

 

TOTAL

 

19427.330

17314.300

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

8877.300

8114.230

 

 

 

 

 

Less

FINANCIAL EXPENSES

 

0.000

0.000

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

 

8877.300

8114.230

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION

 

810.630

833.020

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

 

8066.670

7281.210

 

 

 

 

 

Less

TAX

 

1745.280

1538.810

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

 

6321.390

5742.400

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

 

63.18

57.08

 

LEGAL CASES

 

 

Case Details

 

Bench:-Bombay

 

Presentation Date:-

14/02/2017

Lodging No.:-

NMSL/356/2017

Filing Date:-

14/02/2017

Reg. No.:-

NMCD/454/2017

Reg. Date:-

10/08/2017

 

 

Main Matter

 

Lodging No.:-

SL/98/2017

Reg No.:-

COMS/562/2017

 

 

Petitioner:-

CADILA HEALTHCARE LIMITED -

 

Respondent:-

USV PRIVATE LIMITED AND ANR -

 

 

Petn.Adv.:-

NAYAN RAWAL AND ASSOCIATES (I4693)

 

 

District:-

MUMBAI

 

 

Bench:-

SINGLE

Status:-

Pre-Admission

Category:-

NOTICE OF MOTIONS IN COMMERCIAL DIVISION MATTERS

 

Last Date:-

09/08/2017

Stage:-

NOTICE OF MOTION FOR HEARING

 

Last Coram:-

REGISTRAR(OS)/PROTHONOTARY & SR. MASTER

 

 

Act :-

Trade & Trade Merchandise Marks Act

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

Yes

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

No

8

Designation of contact person

No

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

Yes

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

CORPORATE INFORMATION:

 

The company is a private company domiciled in India and incorporated under the provision of the Companies Act, 1956. The Company was converted into a private limited company on 2 November 2015. The Company is engaged in the manufacturing and sale of Active Pharmaceutical Ingredients (API), finished dosages both branded and generics. The Company is a leader in the diabetes and cardio-vascular space, with strong brands in these segments.

 

 

INDEX OF CHARGES:

 

S

No

SRN

Charge Id

Charge Holder Name

Date of Creation

Date of Modification

Date of Satisfaction

Amount

Address

1

C19478908

10302134

AXIS BANK LIMITED

21/07/2011

-

25/08/2014

800000000.0

TRISHUL 3RD FLOOR OPP SAMARTHESHWAR TEMPLELAW GARDEN ELLISBRIDGE AHMEDABAD GJ380006IN

2

C19480565

10301593

AXIS BANK LIMITED

21/07/2011

-

25/08/2014

800000000.0

TRISHUL 3RD FLOOR OPP SAMARTHESHWAR TEMPLELAW GARDEN ELLISBRIDGE AHMEDABAD GJ380006IN

3

B95557625

80053216

STATE BANK OF INDIA

14/12/1999

21/10/2013

15/01/2014

390000000.0

MID CORPORATE LOAN ADM.UNIT, SHREE HARI BLDG.,RTO LANE, FOUR BUNGLOWS, ANDHERI (WEST) MUMBAI MH400053IN

4

B80008436

10181441

DEPARTMENT OF BIOTECHNOLOGY

15/10/2009

10/06/2010

07/07/2013

11950000.0

BLOCK 2, CGO COMPLEX NEW DELHI DL110003IN

 

 

FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Machinery

·         Furniture and Fixture

·         Office Equipment

·         Computer

·         Vehicles

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 65.35

UK Pound

1

INR 92.70

Euro

1

INR 80.80

 

INFORMATION DETAILS

 

Information Gathered by :

KMN

 

 

Analysis Done by :

PRY

 

 

Report Prepared by :

NKT

 

 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.